The available clinical data are discordant with regard to PD-L1 expression in EGFR-mutated NSCLC,93,94 with two meta-analyses failing to confirm a positive correlation with EGFR mutations, probably for differences in the types of specimens analyzed and in the PD-L1 testing.95 This evidence concerns the gene CD274 and non-small cell lung carcinoma.